RxDoctor Payments Data

Jennifer Patterson, MD

Family Medicine · Independence, MONPI 1083873558

Payments from drug & device makers

$6,939in general payments, 2019–2025

Across 449 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$778
  • Lilly USA, LLC$662
  • Pfizer$567
  • AstraZeneca$482
  • Boehringer Ingelheim$372
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,914100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,939 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$51,332
Medicare patients
235
Services billed
1,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$161,208
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$63,266
JardianceEmpagliflozin61$62,306
MounjaroTirzepatide34$56,917
MyrbetriqMirabegron76$54,855
EliquisApixaban52$53,155
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr67$47,362
FarxigaDapagliflozin Propanediol28$39,908
Tresiba Flextouch U-200Insulin Degludec29$34,776
Stiolto RespimatTiotropium Br/Olodaterol Hcl30$30,609
RybelsusSemaglutide21$29,359
XareltoRivaroxaban22$27,187
Tresiba Flextouch U-100Insulin Degludec44$23,770
LinzessLinaclotide18$22,833
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$22,395

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$778$190,56898 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy$329$117,037156 claims
Boehringer IngelheimJardiance, Stiolto Respimat$372$92,91591 claims
PfizerEliquis, Abrysvo$567$71,307115 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$482$69,18281 claims
Lilly USA, LLCMounjaro$662$56,91734 claims
Astellas Pharma US IncMyrbetriq$198$54,85576 claims
AbbVieLinzess, Creon$1,402$35,32736 claims
Johnson & JohnsonXarelto$173$27,18722 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$69$17,01013 claims
Sumitomo Pharma America, Inc.Gemtesa$69$13,47551 claims
MerckBelsomra$64$8,36716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →